Table 2 Changes in vascular measures from baseline to 8-weeks in response to the interventions
Vascular measures | Glargine | Glargine + Lispro | Glargine + Exenatide | ||||||
|---|---|---|---|---|---|---|---|---|---|
mean | 95%CI | P | mean | 95%CI | P | mean | 95%CI | P | |
Systolic BP (mmHg) | − 3.7 | (− 10.2 to 2.7) | 0.24 | − 2.3 | (− 9.0 to 4.5) | 0.50 | − 8.1 | (− 13.9 to − 2.4) | 0.008 |
Diastolic BP (mmHg) | − 3.7 | (− 7.9 to − 0.5) | 0.08 | − 0.5 | (− 3.9 to 2.8) | 0.74 | − 5.1 | (− 9.0 to − 1.3) | 0.012 |
Heart rate (bpm) | 0.0 | (− 3.8 to 3.9) | 0.99 | 0.2 | (− 4.5 to 4.9) | 0.92 | 0.7 | (− 2.3 to 3.8) | 0.62 |
RHI | 0.2 | (− 0.04 to 0.44) | 0.10 | 0.17 | (− 0.14 to 0.47) | 0.27 | − 0.03 | (− 0.14 to 0.08) | 0.58 |